Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Hepatitis C

  Free Subscription


24.09.2018

1 Dig Dis Sci
1 Eur J Gastroenterol Hepatol
3 J Hepatol
1 J Med Virol
1 J Viral Hepat
1 J Virol
1 Lancet
1 Lancet Infect Dis
1 Transplantation


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Dig Dis Sci

  1. SHERMAN KE, Rouster SD, Kang M, Umbleja T, et al
    PNPLA3 Gene Polymorphisms in HCV/HIV-Coinfected Individuals.
    Dig Dis Sci. 2018 Sep 14. pii: 10.1007/s10620-018-5278.
    PubMed     Text format     Abstract available


    Eur J Gastroenterol Hepatol

  2. ATTIA D, Deterding K, Cornberg J, Gebel MJ, et al
    Different kinetics of liver stiffness using shear wave elastography in patients with chronic hepatitis C infection treated with interferon-free regimens.
    Eur J Gastroenterol Hepatol. 2018 Sep 19. doi: 10.1097/MEG.0000000000001259.
    PubMed     Text format     Abstract available


    J Hepatol

  3. DEUFFIC-BURBAN S, Huneau A, Verleene A, Brouard C, et al
    Assessing the cost-effectiveness of hepatitis C screening strategies in France.
    J Hepatol. 2018;69:785-792.
    PubMed     Text format     Abstract available

  4. NEWSUM AM, Molenkamp R, van der Meer JT, Rebers SP, et al
    Persistence of NS5B-S282T, a sofosbuvir resistance-associated substitution, in a HIV/HCV-coinfected MSM with risk of onward transmission.
    J Hepatol. 2018;69:968-970.
    PubMed     Text format    

  5. BERENGUER M, de la Rosa Rodriguez G, Dominguez-Gil B
    Significant impact of new oral therapies against HCV on the waiting list for liver transplantation in Spain.
    J Hepatol. 2018;69:966-968.
    PubMed     Text format    


    J Med Virol

  6. WAHID B, Waqar M, Rasool N, Wasim M, et al
    Prevalence of TSH dysfunction among sofosbuvir-treated HCV infected patients: a real-world clinical experience.
    J Med Virol. 2018 Sep 19. doi: 10.1002/jmv.25319.
    PubMed     Text format     Abstract available


    J Viral Hepat

  7. YANG R, Gui X, Xiong Y, Gao S, et al
    Long-term Follow-up of Patients Triply Infected with HIV and Hepatitis B and C Viruses in a Comprehensive Hospital in Central China.
    J Viral Hepat. 2017 Jun 20. doi: 10.1111/jvh.12739.
    PubMed     Text format     Abstract available


    J Virol

  8. DOMINGUEZ-MOLINA B, Machmach K, Perales C, Tarancon-Diez L, et al
    Toll Like Receptor-7 and -9 agonists improve Hepatitis C Virus replication and infectivity inhibition by plasmacytoid dendritic cells.
    J Virol. 2018 Sep 19. pii: JVI.01219-18. doi: 10.1128/JVI.01219.
    PubMed     Text format     Abstract available


    Lancet

  9. WANDELER G, Coffie PA, Kuniholm MH, Ocama P, et al
    Issues with measuring hepatitis prevalence in resource-limited settings.
    Lancet. 2018;391:835-836.
    PubMed     Text format    


    Lancet Infect Dis

  10. SHIMAKAWA Y, Pourette D, Bainilago L, Enel C, et al
    Improving communication about viral hepatitis in Africa.
    Lancet Infect Dis. 2017;17:688-689.
    PubMed     Text format    


    Transplantation

  11. WALLER KMJ, Wyburn KR, Shackel NA, O'Leary MJ, et al
    Hepatitis transmission risk in kidney transplantation (the HINT study): a cross-sectional survey of transplant clinicians in Australian and New Zealand.
    Transplantation. 2017 Jul 21. doi: 10.1097/TP.0000000000001885.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis C is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: